Particle Sciences offers microfluidics reaction technology for
10 May 2010
Drug development services provider Particle Sciences and
Microfluidics have extended their collaboration with the placement of
the newly-announced Microfluidics Reaction Technology (MRT) system at
This revolutionary technology combines a high shear, high pressure
impinging jet processor with expert process development to produce
nanoparticles and continuous pharmaceutical manufacturing through
crystallization and chemical reactions.
According to Robert Lee, Ph.D., Vice President of Pharmaceutical
Development at Particle Sciences, "Particle Sciences is extremely
pleased with the potential of MRT and we have successfully used it
with several client-driven projects. It definitely provides a unique
approach to bottom-up nanoparticle formulation, one that lends
itself to being scaled and conforming to cGMP requirements."
According to Bill Kober, Vice President of Sales, Americas, at
Microfluidics, "According to a recent independent survey,
approximately 80% of pharmaceutical companies are planning to invest
in continuous manufacturing in 2010. MRT offers exclusive results
that cannot be achieved via any other method. However, it requires
more than a machine.
"Particle Sciences was chosen as an early site for the technology
because of their deep knowledge around both pharmaceutical
formulation and nanoparticle engineering. We are confident that
their experienced engineers are fully trained and capable of
developing processes for customers which will meet their precise and
most demanding requirements."